# Shi Yina

> Shi Yina is a Series A investor at Sherpa Healthcare Partners backing Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Sherpa Healthcare Partners](https://shizune.co/investors/profile/sherpa-venture-capital)
- Total investments: 1
- Last investment: Dec 2021
- Lead investor: 0%
- Last updated: Aug 2026

Shi Yina is a Series A investor at Sherpa Healthcare Partners focused on Health Care and Biotechnology. Shi Yina, Managing Director of Sherpa Investment.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |
| Artificial Intelligence | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MindRank AI | MindRank AI is a developer of proprietary end-to-end AI-driven drug discovery platform (Molecule Pro™). | $19M | Series A | Dec 15, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Green Pine Capital Partners](https://shizune.co/investors/profile/green-pine-capital-partners) — VC Fund, 1 deal together
- [Huagai Capital](https://shizune.co/investors/profile/huagai-capital) — VC Fund, 1 deal together

## About Sherpa Healthcare Partners

VC Fund · Beijing, China

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

5 contacts available at Sherpa Healthcare Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Daqing Cai | founder and Managing partner | https://shizune.co/investors/profile/cai-daqing |
| Darren Cai | Founder & Managing Partner | https://shizune.co/investors/profile/darren-cai |
| He Zhu | Vice President | https://shizune.co/investors/profile/he-zhu |
| Ouyang Xiangyu | Co-Founder & Managing Partner | https://shizune.co/investors/profile/ouyang-xiangyu-b45d |
| Shi Yina | Managing Director | https://shizune.co/investors/profile/shi-yina |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Shi Yina invest in?

Shi Yina invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Shi Yina last invest?

The most recent investment recorded for Shi Yina closed in Dec 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co